Neurothera Labs Inc (NTLX.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 01/31
(Values in thousands)
| 10-2021 | 07-2021 | 04-2021 | |
| Cash Flows From Operating Activities | |||
| Accounts receivable | -2 | -1 | -1 |
| Other Working Capital | -8 | 9 | -5 |
| Other Operating Activity | -39 | -62 | -14 |
| Operating Cash Flow | $-48 | $-54 | $-20 |
| Cash Flows From Investing Activities | |||
| Investing Cash Flow | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||
| Common Stock Issued | 0 | 200 | 0 |
| Financing Cash Flow | $0 | $200 | $0 |
| Beginning Cash Position | 271 | 125 | 145 |
| End Cash Position | 223 | 271 | 125 |
| Net Cash Flow | $-48 | $146 | $-20 |
| Free Cash Flow | |||
| Operating Cash Flow | -48 | -54 | -20 |
| Free Cash Flow | -48 | -54 | -20 |